News
Important Only
Other
Tvardi Therapeutics Announces First Quarter 2025 Results And Provides Business Update
May 13 (Reuters) - Tvardi Therapeutics Inc TVRD.O:TVARDI THERAPEUTICS ANNOUNCES FIRST QUARTER 2025 RESULTS AND PROVIDES BUSINESS UPDATETVARDI THERAPEUTICS: CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS AT CLOSING ANTICIPATED TO BE SUFFICIENT TO FUND OPERATIONS INTO 2H 2026TVARDI THERAPEUTICS: ON...Reuters
Tue, May 13
Other
Intellicheck Q1 Revenue USD 4.894 Million Versus. IBES Estimate USD 4.78 Million
May 13 (Reuters) - Intellicheck Inc IDN.O:INTELLICHECK Q1 REVENUE USD 4.894 MILLION VERSUS. IBES ESTIMATE USD 4.78 MILLIONINTELLICHECK Q1 OPERATING EXPENSES USD 4.74 MILLIONINTELLICHECK Q1 INCOME FROM OPERATIONS USD -348 THOUSANDINTELLICHECK Q1 NET INCOME USD -318 THOUSANDINTELLICHECK Q1 GROSS PROFI...Reuters
Tue, May 13
Other
As fire truck prices hit $2 million, US firefighters demand an antitrust probe
Prices have doubled in 10 years, union saysSome cities wait years for new trucksGroups also call for study of equipment, partsCompanies cite COVID-19 among delay reasonsBy Jody GodoyMay 13 (Reuters) - The largest firefighters' labor union in the U.S. is demanding antitrust authorities investigat...Reuters
Tue, May 13
Stocks
EMERGING MARKETS-Latam assets gain as trade war tensions ease; Trump's Gulf tour on radar
MSCI Latin American currencies index near one-year highBrazil's central bank signals prolonged high ratesUS to remove Syria sanctions, secures Saudi Arabian investmentChina offers Latin America, Caribbean billions to rival US influenceBy Nikhil Sharma, Johann M Cherian and Purvi Agarwal May 1...Reuters
Tue, May 13
Other
Anebulo Pharmaceuticals, Inc. Q3 Basic EPS USD -0.04
May 13 (Reuters) - Anebulo Pharmaceuticals Inc ANEB.O:ANEBULO PHARMACEUTICALS, INC. Q3 BASIC EPS USD -0.04ANEBULO PHARMACEUTICALS, INC. Q3 OPERATING EXPENSES USD 1.9 MILLIONANEBULO PHARMACEUTICALS, INC. Q3 NET INCOME USD -1.7 MILLIONANEBULO PHARMACEUTICALS, INC. Q3 EPS USD -0.04Reuters
Tue, May 13
Other
Fluent Inc expected to post a loss of 30 cents a share - Earnings Preview
Fluent Inc FLNT.OQ FLNT.O is expected to show a fall in quarterly revenue when it reports results on May 15 for the period ending March 31 2025The New York City-based company is expected to report a 13.2% decrease in revenue to $57.293 million from $65.98 million a year ago, according to the mean ...Reuters
Tue, May 13
Other
Chime Financial Inc Files For IPO
May 13 (Reuters) - CHIME FINANCIAL INC FILES FOR IPO - SEC FILINGCHIME FINANCIAL INC SAYS APPLIED TO LIST CLASS A COMMON STOCK ON NASDAQ UNDER SYMBOL “CHYM”CHIME FINANCIAL INC SAYS MORGAN STANLEY, GOLDMAN SACHS & CO LLC, J.P. MORGAN, BARCLAYS AND EVERCORE ISI ARE AMONG UNDERWRITERS TO IPOCHIME F...Reuters
Tue, May 13
Other
Hyperfine Inc. Q1 Sales USD 2.137 Million Versus. Ibes Estimate USD 2.81 Million
May 13 (Reuters) - Hyperfine Inc HYPR.O:HYPERFINE, INC. Q1 SALES USD 2.137 MILLION VERSUS. IBES ESTIMATE USD 2.81 MILLIONHYPERFINE, INC. Q1 OPERATING EXPENSES USD 11.785 MILLIONHYPERFINE, INC. Q1 OPERATING INCOME USD -10.902 MILLION VERSUS. IBES ESTIMATE USD -9.44 MILLIONHYPERFINE, INC. Q1 NET INCOM...Reuters
Tue, May 13
Other
Genasys Inc. Q2 Adjusted EBITDA USD -5.149 Million
May 13 (Reuters) - Genasys Inc GNSS.O:GENASYS INC. Q2 ADJUSTED EBITDA USD -5.149 MILLIONGENASYS INC. Q2 NET INCOME USD -6.139 MILLIONGENASYS INC. Q2 GROSS PROFIT USD 2.61 MILLIONGENASYS INC. Q2 INCOME FROM OPERATIONS USD -6.255 MILLIONGENASYS INC. Q2 PRETAX PROFIT USD -6.068 MILLIONGENASYS INC. Q2 R...Reuters
Tue, May 13
Stocks
Edesa Biotech Inc expected to post a loss of 29 cents a share - Earnings Preview
Edesa Biotech Inc EDSA.OQ EDSA.O is expected to show no change in quarterly revenue when it reports results on May 15 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Edesa Biotech Inc is for a loss of 29 cents per share. The one available analyst rating on the s...Reuters
Tue, May 13
Other
TransAct Technologies Q1 Operating Income USD -15 Thousand
May 13 (Reuters) - TransAct Technologies Inc TACT.O:TRANSACT TECHNOLOGIES Q1 OPERATING INCOME USD -15 THOUSANDTRANSACT TECHNOLOGIES Q1 GROSS MARGIN 48.7%TRANSACT TECHNOLOGIES Q1 EPS USD 0TRANSACT TECHNOLOGIES Q1 NET INCOME USD 19 THOUSANDTRANSACT TECHNOLOGIES Q1 ADJUSTED EBITDA USD 544 THOUSANDTRANS...Reuters
Tue, May 13
